ERZYDO Trademark

Trademark Overview

On Thursday, May 26, 2022, a trademark application was filed for ERZYDO with the United States Patent and Trademark Office. The USPTO has given the ERZYDO trademark a serial number of 97429872. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, April 22, 2025. This trademark is owned by Johnson & Johnson. The ERZYDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders
erzydo

General Information

Serial Number97429872
Word MarkERZYDO
Filing DateThursday, May 26, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, April 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 30, 2022NEW APPLICATION ENTERED
Thursday, June 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 14, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2023SOU EXTENSION 1 FILED
Thursday, November 30, 2023SOU EXTENSION 1 GRANTED
Saturday, December 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 2 GRANTED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU EXTENSION 2 FILED
Wednesday, January 22, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, January 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 22, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 22, 2025SOU EXTENSION 4 FILED
Tuesday, April 22, 2025SOU EXTENSION 4 GRANTED
Wednesday, April 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2024SOU EXTENSION 3 FILED
Friday, November 15, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 24, 2025SOU EXTENSION 3 GRANTED

Related Keywords

erzydo diseases disorders oncological treatment preparations pharmaceutical